Mericitabine (RG-7128) is an antiviral drug, a deoxycytidine analog (a type of nucleoside analog).

It was developed as a treatment for hepatitis C, acting as a NS5B RNA polymerase inhibitor, but while it showed a good safety profile in clinical trials, it was not sufficiently effective to be used as a stand-alone agent.

However mericitabine has been shown to boost the efficacy of other antiviral drugs when used alongside them, and as most modern treatment regimens for hepatitis C use a combination therapy of several antiviral drugs, clinical trials have continued to see if it can form a part of a clinically useful drug treatment program.

This antiinfective drug article is a stub.

You can help Wikipedia by expanding it.